Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ardelyx Inc (ARDX)

Ardelyx Inc (ARDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 94,452
  • Shares Outstanding, K 144,599
  • Annual Sales, $ 10,100 K
  • Annual Income, $ -158,170 K
  • 60-Month Beta 1.84
  • Price/Sales 9.67
  • Price/Cash Flow N/A
  • Price/Book 1.52
Trade ARDX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.39
  • Most Recent Earnings -0.21 on 05/05/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 181.13% ( +88.62%)
  • Historical Volatility 131.93%
  • IV Percentile 67%
  • IV Rank 24.67%
  • IV High 507.68% on 11/22/21
  • IV Low 74.16% on 05/21/21
  • Put/Call Vol Ratio 0.10
  • Today's Volume 169
  • Volume Avg (30-Day) 1,942
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 68,595
  • Open Int (30-Day) 63,830

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.19
  • Number of Estimates 4
  • High Estimate -0.17
  • Low Estimate -0.20
  • Prior Year -0.45
  • Growth Rate Est. (year over year) +57.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5770 +13.21%
on 05/11/22
1.0800 -39.52%
on 04/25/22
-0.1182 (-15.32%)
since 04/20/22
3-Month
0.5770 +13.21%
on 05/11/22
1.3800 -52.67%
on 04/04/22
-0.0398 (-5.74%)
since 02/18/22
52-Week
0.5770 +13.21%
on 05/11/22
2.1500 -69.62%
on 07/20/21
-1.0543 (-61.75%)
since 05/20/21

Most Recent Stories

More News
Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates

Ardelyx (ARDX) delivered earnings and revenue surprises of -5% and 87.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ARDX : 0.6532 (-3.23%)
LJPC : 3.94 (-2.96%)
Ardelyx (ARDX) Reports Q4 Loss, Misses Revenue Estimates

Ardelyx (ARDX) delivered earnings and revenue surprises of -24% and 48.55%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ARDX : 0.6532 (-3.23%)
BVS : 8.46 (-2.20%)
Aerie Pharmaceuticals (AERI) Tops Q4 Earnings and Revenue Estimates

Aerie (AERI) delivered earnings and revenue surprises of 260.29% and 272.10%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

AERI : 6.81 (-4.62%)
ARDX : 0.6532 (-3.23%)
Are Options Traders Betting on a Big Move in Ardelyx (ARDX) Stock?

Investors need to pay close attention to Ardelyx (ARDX) stock based on the movements in the options market lately.

ARDX : 0.6532 (-3.23%)
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ardelyx, Inc. (NASDAQ: ARDX) on behalf of long-term stockholders following a...

ARDX : 0.6532 (-3.23%)
Implied Volatility Surging for Ardelyx (ARDX) Stock Options

Investors need to pay close attention to Ardelyx (ARDX) stock based on the movements in the options market lately.

ARDX : 0.6532 (-3.23%)
Is a Surprise Coming for Ardelyx (ARDX) This Earnings Season?

Ardelyx (ARDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ARDX : 0.6532 (-3.23%)
Editas (EDIT) to Report Q3 Earnings: What's in the Cards?

On Editas' (EDIT) third-quarter earnings call, investor focus will likely be on the company's progress with the development of its lead pipeline candidate, EDIT-101.

ABBV : 151.01 (-0.47%)
ARDX : 0.6532 (-3.23%)
EDIT : 11.02 (+0.73%)
GMTX : 1.3500 (-5.59%)
Ardelyx Announces Four Tenapanor Presentations at ASN's Kidney Week 2021

/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative...

ARDX : 0.6532 (-3.23%)
Flexion (FLXN) to Report Q3 Earnings: What's in the Cards?

On Flexion's (FLXN) third-quarter earnings call, investor focus will be on its updates on earnings and revenues and the upcoming merger with Pacira whereby the latter will acquire the former.

PCRX : 63.59 (+0.87%)
FLXN : 9.12 (-0.22%)
ARDX : 0.6532 (-3.23%)
GMTX : 1.3500 (-5.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase...

See More

Key Turning Points

3rd Resistance Point 0.7588
2nd Resistance Point 0.7244
1st Resistance Point 0.6888
Last Price 0.6532
1st Support Level 0.6188
2nd Support Level 0.5844
3rd Support Level 0.5488

See More

52-Week High 2.1500
Fibonacci 61.8% 1.5491
Fibonacci 50% 1.3635
Fibonacci 38.2% 1.1779
Last Price 0.6532
52-Week Low 0.5770

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar